Phreesia: Depressed Valuation, Improving Profitability, and Activist Support Create Compelling Upside Potential

William Blair analyst Ryan Daniels has reiterated their bullish stance on PHR stock, giving a Buy rating on April 15.

Ryan Daniels has given his Buy rating due to a combination of factors, including Phreesia’s strong path toward substantially higher profitability and the stock’s depressed valuation. He highlights that headcount discipline, operational efficiencies, and stable stock-based compensation should support adjusted EBITDA margins approaching 30% and a sharp improvement in GAAP earnings over the next several years.

Daniels also emphasizes that his detailed forecasts point to earnings meaningfully outperforming current consensus, creating potential equity upside of roughly 65% to more than 100% over the next two years. In his view, the recent share price decline, coupled with activist involvement that adds downside protection, creates an attractive risk/reward setup that justifies maintaining a positive stance on the stock despite near-term revenue guidance cuts and sector-wide concerns about AI and regulatory pressures.

In another report released on April 15, RBC Capital also maintained a Buy rating on the stock with a $19.00 price target.